Skip to main content
UCSF Medical Center
UCSF Benioff Children's Hospitals
UCSF Logo
  • UCSF Logo
  • Specialties
      • Cancer

      • Cardiology & Heart Surgery

      • Dermatology

      • Endocrinology & Endocrine Surgery

      • Fetal Treatment

      • Gastroenterology

      • Infectious Disease

      • Neurology

      • Neurosurgery

      • Ophthalmology

      • Orthopedics

      • Otolaryngology – Head and Neck Surgery

      • Pediatrics

      • Pulmonology

      • Spine

      • Surgery

      • Urology

      • Women's Health

  • COVID-19
  • About Us
  • Refer a Patient
      • Refer a Patient

      • Refer a Pediatrics Patient

      • Transfer a Patient

      • Request a Consultation

      • UCSF MD Link

  • Clinical Trials

David Oh, MD

Medical oncologist

David Oh, MD

Dr. David Oh is a medical oncologist who cares for patients who are receiving novel immunotherapies for cancers as part of clinical trials. These are treatments that harness the patient's own immune system to fight cancer. He specializes in prostate and bladder cancers.

Oh's research focuses on understanding and improving cancer immunotherapies. He leads clinical trials to evaluate new immunotherapies for solid tumors, and he studies samples from patients who have received immunotherapies with the goal of better understanding their benefits and side effects.

Oh earned his medical degree from Stanford University School of Medicine, where he also completed a doctorate in physiology. At UCSF, he completed a residency in internal medicine and a fellowship in hematology and oncology.

Oh is a member of the American Society of Clinical Oncology, American Association for Cancer Research and Society for Immunotherapy of Cancer. He has received Young Investigator Awards from the Prostate Cancer Foundation, Bladder Cancer Advocacy Network and Conquer Cancer Foundation of the American Society of Clinical Oncology.

View Full Profile

View Profile


Related Videos

Cancer Immunotherapy: Promise and Pitfalls Video

Cancer Immunotherapy: Promise and Pitfalls

Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.

Additional Links

  • Refer a Patient

  • Find a Doctor

  • Medical Services

  • Clinical Trials

  • Continuing Medical Education

This Video Content is available for informational and educational purposes only. UCSF does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Video Content. The Regents of the University of California and its officers, agents or employees (UCSF) will not be liable for any damages of any kind arising from any use of the Video Content, which is provided as is, and without warranties. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.

©2002 - 2022 The Regents of The University of California